High-Frequency Oscillation vs Mechanical Ventilation for Neonatal Acute Respiratory Distress Syndrome
High-Frequency Oscillation vs mechanische Beatmung bei neonatalem akutem Atemnotsyndrom
JAMA Network Open · 09.03.2026 · 9 (3) · e260268
DOI: 10.1001/jamanetworkopen.2026.0268 ↗Auf einen Blick
Bei Frühgeborenen mit neonatalem akutem Atemnotsyndrom senkte elektive HFOV im Vergleich zur CMV die Rate an bronchopulmonaler Dysplasie. Für andere neonatale Endpunkte zeigte sich kein signifikanter Unterschied.
Fragestellung
Ist HFOV bei Frühgeborenen mit NARDS der CMV bei der Reduktion von bronchopulmonaler Dysplasie und anderen neonatalen Endpunkten überlegen?
Methode
Einzentrische randomisierte klinische Studie bei Frühgeborenen mit NARDS; Randomisierung zu fortgesetzter CMV oder elektiver HFOV; Analyse mit modifizierter Poisson- und Cox-Regression.
Ergebnisse
386 Frühgeborene wurden randomisiert: 181 HFOV, 205 CMV. BPD: 34,3 % vs. 44,9 %; RR 0,76 (95 %-KI 0,59–0,98) nach Definition 1 und 17,1 % vs. 25,4 %; RR 0,68 (95 %-KI 0,45–1,00) nach Definition 2. Für weitere Endpunkte kein signifikanter Unterschied.
Schlussfolgerung der Autor:innen
Die Studie ergab, dass elektive HFOV die Inzidenz von BPD bei Frühgeborenen mit NARDS im Vergleich zur CMV senkte und eine vielversprechende Strategie zur BPD-Prävention sein könnte.
Kernaussagen
- BPD seltener unter elektiver HFOV als unter CMV
- Kein signifikanter Unterschied bei Tod und weiteren neonatalen Komplikationen
- Einzentrische randomisierte klinische Studie mit 386 Frühgeborenen
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JAMA Network Open, online erschienen am 09.03.2026. Verfasst von Jie Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Respiratory Distress Syndrome, Newborn, High-Frequency Ventilation, Respiration, Artificial, Bronchopulmonary Dysplasia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Beatmung und Weaning
Abstract (Originalsprache)
Importance Key clinical features of neonatal acute respiratory distress syndrome (NARDS) are broadly comparable to those observed in pediatric and adult ARDS; however, evidence is insufficient to recommend high-frequency oscillatory ventilation (HFOV) or conventional mechanical ventilation (CMV) as the preferred first-line therapy.
Objective
To evaluate whether HFOV is superior to CMV in reducing bronchopulmonary dysplasia (BPD) and other neonatal adverse outcomes, including death, among preterm infants (≤34 weeks’ gestational age) with NARDS. Design, Setting, and Participants This single-center randomized clinical trial conducted from August 1, 2019, to December 31, 2023, enrolled preterm infants born between 25 weeks 0 days and 34 weeks 6 days of gestation with NARDS who were stabilized with CMV. Data were analyzed from October to December 2024.
Intervention
Participants were randomly assigned to continue CMV or transition to elective HFOV. Main Outcomes and Measures The primary outcome was BPD, assessed using 2 definitions: definition 1, that of the 2001 Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and definition 2, one based on 2019 research. Secondary outcomes included death, retinopathy of prematurity (higher than stage 2), necrotizing enterocolitis (stage 2 or higher), intraventricular hemorrhage (grade 3 or higher), air leak, and hemodynamically significant patent ductus arteriosus. Modified Poisson regression, and Cox proportional hazards regression were applied for outcome risk assessment where applicable.
Results
A total of 386 preterm infants (230 male [59.6%]; mean [SD] maternal age, 29.9 [4.8] years) were randomized: 181 to elective HFOV and 205 to CMV. Overall, 154 (39.9%) and 83 (21.5%) developed BPD according definitions 1 and 2, respectively. Elective HFOV reduced the risk of BPD by 24.0% (34.3% vs 44.9%; relative risk, 0.76; 95% CI, 0.59-0.98) according to definition 1 and by 32.0% (17.1% vs 25.4%; relative risk 0.68; 95% CI, 0.45-1.00) according to definition 2 compared with CMV. No significant between-group differences were observed for death, higher than stage 2 retinopathy of prematurity, stage 2 or higher necrotizing enterocolitis, grade 3 or higher intraventricular hemorrhage, air leak, or hemodynamically significant patent ductus arteriosus. Sensitivity analysis excluding 44 participants who crossed over between treatment groups did not significantly attenuate the estimates. Conclusions and Relevance This randomized clinical trial found that elective HFOV reduced the incidence of BPD in preterm infants born at 34 weeks’ gestation or earlier with NARDS compared with CMV. The results of this study suggest that elective HFOV is a promising strategy for preventing BPD in this high-risk population, especially the more severe forms linked to increased long-term morbidity and mortality. Trial Registration ClinicalTrials.gov Identifier: NCT03591796 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Neonatology, Children's Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing, China.
- National Clinical Research Center for Child Health and Disorders, Chongqing, China.
- China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing, China.
- Chongqing Key Laboratory of Pediatrics, Chongqing, China.
- Bia-Echo Asia Centre for Reproductive Longevity and Equality, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Zitieren
APA
Li, J., Liu, K., Yang, Q., Tan, Q., Feng, Z., Shi, Y., Chen, L., & Li, L. J. (2026). High-Frequency Oscillation vs Mechanical Ventilation for Neonatal Acute Respiratory Distress Syndrome. JAMA Network Open, 9(3), e260268. https://doi.org/10.1001/jamanetworkopen.2026.0268
Vancouver
Li J, Liu K, Yang Q, Tan Q, Feng Z, Shi Y, et al. High-Frequency Oscillation vs Mechanical Ventilation for Neonatal Acute Respiratory Distress Syndrome. JAMA Network Open. 2026;9(3):e260268. doi:10.1001/jamanetworkopen.2026.0268
BibTeX
@article{Li2026,
author = {Li, Jie and Liu, Kaizhen and Yang, Qian and Tan, Qin and Feng, Zhichun and Shi, Yuan and Chen, Long and Li, Ling-Jun},
title = {High-Frequency Oscillation vs Mechanical Ventilation for Neonatal Acute Respiratory Distress Syndrome},
journal = {JAMA Network Open},
year = {2026},
volume = {9},
number = {3},
pages = {e260268},
doi = {10.1001/jamanetworkopen.2026.0268}
}
EUVIMED